A study has shown that increased DNA methylation levels of the brain-derived neurotrophic factor (BDNF) promoter result in reduced BDNF mRNA protein expression and add a higher risk of AD development (Xie et al., 2017). Here, BDNF is linked to Alzheimer disease.